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Macrophages have been found to regulate the eﬀects of biomaterials throughout the entire tissue repair process as an antigen-
presenting cell. As a well-deﬁned osteoconductive biomaterial for bone defect regeneration, tricalcium phosphate (TCP) has
been found to facilitate a favourable osteoimmunomodulatory response that can shift macrophage polarization towards the M2
phenotype. In the present study, our group discovered that a histone methyltransferase enhancer of zeste1 (EZH1) was
drastically downregulated in Thp1 cells stimulated by TCP, indicating that EZH1 may participate in the macrophage phenotype
shifting. Furthermore, the NF-κB pathway in macrophages was signiﬁcantly downregulated through stimulation of TCP,
suggesting a potential interaction between EZH1 and the NF-κB pathway. Utilizing gene knock-down therapy in macrophages,
it was found that depletion of EZH1 induced M2 macrophage polarization but did not downregulate NF-κB. When the NF-κB
pathway was inhibited, the expression of EZH1 was signiﬁcantly downregulated, suggesting that the inhibition of EZH1 may be
regulated by the NF-κB pathway. These novel ﬁndings provide valuable insights into a potential gene target system that controls
M2 macrophage polarization which ultimately favours a microenvironment suitable for bone repair.
1. Introduction
As a type of antigen-presenting cell, macrophages have
been found to regulate implanted biological materials dur-
ing the tissue repair process [1]. The strong plasticity of
macrophages enables their dual function that favours
either tissue inﬂammation or tissue repair, which have
made macrophages an ideal research target in the ﬁeld of
tissue engineering [2, 3]. With changes to the surrounding
microenvironment, macrophages can polarize into two
phenotypes, either M1 (tissue inﬂammation) or M2 (tissue
repair) macrophages. It is generally accepted that the M1
macrophage produces a number of proinﬂammatory cyto-
kines including IL-6, IL-12, and TNF-alpha, thereby reduc-
ing osteogenic diﬀerentiation [4]. On the contrary, M2
macrophages are responsible for tissue repair macrophage
and hence secrete pro-wound-healing cytokines and growth
factors including TGF-β, VEGF, and IFG-1 to promote
immunoregulation and tissue repair [5]. Therefore, balan-
cing the microenvironment and macrophage polarization
between M1 and M2 phenotypes is critical for proper bioma-
terial implant integration.
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As a well-deﬁned osteoconductive biomaterial for bone
regeneration, tricalcium phosphate (TCP) has broad clinical
applications [6, 7]. Because of the good absorbability and
osteoconduction characteristics of TCP, it enables bone
remodelling to occur at the material interface [8–10]. Natu-
rally, however, it is important to understand that prior
to bone formation around any biomaterial, immune cells
(namely, macrophages) surround the surface of the biomate-
rial and create a microenvironment that favours either future
bone regeneration or ﬁbrous encapsulation [3].
There have been inconsistencies in the literature deﬁning
the role of macrophages with respect to their contribution to
osteogenesis around TCP bone particles. In a study con-
ducted by Chen et al., it was revealed that macrophage polar-
ization was driven towards the M1 extreme when cobalt was
incorporated into β-tricalcium phosphate and this negatively
impacted the ability for bone-forming osteoblasts to contrib-
ute to new bone formation [11]. Similarly, a study by Tai et al.
found that TCP particles promoted macrophage expression
of CD86, an M1 surface molecule in macrophages [12]. In
contrast, however, a study by Chen et al. found that TCP
extracts facilitated a favourable osteoimmunomodulatory
response that promotedM2macrophage polarization includ-
ing the release of bone morphogenetic protein-2 (BMP2),
one of the best-known inducers of osteoblast diﬀerentiation
of bone marrow stromal cells (BMSCs) [13, 14].
Currently, numerous studies have shown that histone
methylation modiﬁcation plays an important role in the
polarization of macrophages [15–17]. Previously, our group
revealed that EZH1 can form a nonclassical complex with
SUZ12 and UTX, leading to the assembly of RNA polII to
the target genes of NF-kappa B [18]. NF-kappa B is a key
pathway that mediates macrophage polarizations towards
theM1 phenotype, but whether it can regulate EZH1 remains
unknown. Furthermore, the direct role of EZH1 during mac-
rophage polarization remains unclear [19, 20].
In the present study, we aimed to investigate the potential
role of macrophages during the bone regeneration process in
the femurs of rats implanted with TCP. It was revealed that
TCP signiﬁcantly suppresses the activation of the NF-kappa
B pathway and causes a decrease in EZH1 expression. The
reduction of EZH1 led to lower expression of M1 markers
resulting in a lowered release of proinﬂammatory cytokines.
As a result, it was found that this local microenvironment
favoured bone regeneration. We then set to characterize the
role of EZH1 in the regulation of macrophage polarization
and further aimed to clarify the interaction between EZH1
and NF-kappa B during the bone repair process.
2. Materials and Methods
2.1. In Vivo Studies by Using the Femur Defect Model. The
tricalcium phosphate utilized in this study was purchased
from Olympus Terumo Biomaterials. Six mature Wistar rats
whose body weight ranged from 185 to 235 grams were uti-
lized for the in vivo component of this study. All rats utilized
in this study were handled in accordance with the policies of
the Ethics Committee for Animal Research, Wuhan Univer-
sity, China. Proper sterile conditions and minimally invasive
surgical procedures were utilized throughout the entire sur-
gery and approved by the Ethics Committee for Animal
Use of the Institute of Biomedical Sciences, under protocol
number 134/2012. The animals and surgical protocols were
performed according to our previous studies [21]. Brieﬂy,
the femoral diaphysis was orientated by a direct incision
towards the fascia lata. A bone defect that reached the med-
ullary canal was made by a diamond-tipped drill bit at
4000 rpm irrigated by physiological serum. Then the defect
was ﬁlled with sterilized TCP. Afterwards, the wound was
sutured closed in 2 layers. After one day, 3 rats were sacriﬁced
using sodium pentobarbital (200mg/kg, ip). After 8 weeks,
the remaining three rats were sacriﬁced.
2.2. Hematoxylin-Eosin Staining. After ﬁxing in 4% formal-
dehyde for 48 hours, femoral samples were submersed in
10% EDTA, which was changed every three days for 3 weeks
to decalcify the samples. Then the samples were embedded in
paraﬃn. Samples were cut in 5μm thick sections and each
slide was prepared with two sections. The sections were
stained using hematoxylin-eosin stain (Sigma).
2.3. Cell Culture and Extract Preparation. Thp1 cells were
cultured at 37°C with 5% carbon dioxide in HyClone RPMI
1640 medium modiﬁed (Thermo Fisher Scientiﬁc Inc.),
10% fetal bovine serum (FBS) (Gibco, Life Technologies Cor-
poration), and 100mg/mL streptomycin (HyClone). TCP
was sterilized and placed into 24-well plates (100mg/well)
using a small spatula and then into cultures with 500μL/well
of Thp1 culture medium. After 24h of incubation, the culture
medium was collected as the TCP extract.
Thp1 was ﬁrst induced to macrophages by culture with
100 ng/mL of phorbol myristate acetate (PMA) (Sigma) at a
density of 1× 106 cells/mL for 48h. Then the culture medium
was changed to culture medium containing TCP extract,
500 ng/mL lipopolysaccharide (LPS) (PeproTech), and
20ng/mL human interleukin-4 (IL-4) (PeproTech). After
incubation for 1 h, the supernatants of Thp1 cells cultured
with TCP extract were collected.
Humanbonemarrow stemcells (HBMSCs)were obtained
from patients undergoing iliac bone graft with informed writ-
ten consent. The procedure was approved by the Ethics Com-
mittee at Wuhan University, China. HBMSCs were cultured
in a-MEM medium (Thermo Fisher Scientiﬁc Inc.) at 37°C
with 5% carbon dioxide.
2.4. Gene Silence and Osteogenic Induction. Gene silence in
Thp1 was performed as Lipofectamine 3000 reagent protocol
(Thermo Fisher Scientiﬁc). The target sequence for siRNA
was 5′-CCAAAGUGGUCAUGGUGAATT-3′.
Osteogenic-inducing media were comprised of a-MEM
with 10%FBS, 100U/mLpenicillin, 100mg/mL streptomycin,
10 nMdexamethasone, 10mMbeta-glycerophosphate, 50μg/
mL L-ascorbic acid, and TCP extract, Thp1 supernatants.
2.5. Alizarin Red Staining and Alkaline Phosphatase Staining.
HBMSCs were ﬁrst washed with PBS three times and then
ﬁxed in 4% formaldehyde for 15min after being induced with
osteogenic diﬀerentiation media for 14 days. Then samples
were stained with 0.1% alizarin red solution (pH4.2) at room
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temperature for 1 h. Alkaline phosphatase (ALP) staining
was performed according to the manufacturer’s protocol
(ALP; Beyotime) after HBMSCs were cultured for 7 days.
Quantiﬁcation of the areas of alizarin red staining and ALP
staining was measured by ImageJ software [22]. Stained areas
were designated by normalizing the threshold and then ana-
lysing the size of the stained areas.
2.6. Protein Extraction and Western Blotting. EZH1 silenced
and normal Thp1 cells were treated with TCP extract for
1 h. Then cells were collected with RIPA, mixed with loading
buﬀer, and then heated for 10min at 95°C to denature total
protein for Western blotting. The antibodies against EZH1
(ABclonal, A5818), P65 (Boster, BA0610-2), and P-P65 (Cell
Signaling Technology Inc.) were purchased from the indi-
cated companies.
2.7. Reverse Transcription and Quantitative PCR. Thp1 cells
were treated with PMA for 48 h, and then the culture
medium was replaced with culture medium containing TCP
extract, LPS, and IL-4. After incubation for 1 h, the superna-
tants of Thp1 were collected. Then HBMSC cells were treated
with culture medium including the supernatants from the
Thp1, LPS, IL-4, and TCP extract which contained osteo-
genic diﬀerentiation medium for 14 days. Thp1 cells were
treated with culture medium, LPS, IL-4, and TCP extract
for 2 h to evaluate gene expression for macrophage
polarization. Total RNA was extracted with TRIzol reagent
(TriPure Isolation Reagent, Roche Applied Science, Ger-
many) following the manufacturer’s protocol. About 1μg of
total RNA was used in reverse transcription with PrimeScript
RT-PCR Kit (TaKaRa, Japan) according to the manufac-
turer’s protocol. The primer sequences used in Q-PCR are
shown in Table 1.
2.8. Statistical Analysis. All data analysis was performed
using GraphPad Prism software (San Diego, CA). The sig-
niﬁcance was set at p < 0 05. Data was calculated as a
mean, and the statistical signiﬁcance of diﬀerences between
diﬀerent groups was examined by one-way ANOVA and
t-test. GAPDH was used as housekeeping gene. ∗p < 0 05,
∗∗p < 0 01, ∗∗∗p < 0 001, and ∗∗∗∗p < 0 0001.
3. Results
3.1. TCP Scaﬀolds Promote Bone Regeneration and BMSC
Osteogenic Diﬀerentiation. To conﬁrm the ability of TCP
scaﬀolds during bone regeneration and to investigate the
potential bone-promoting mechanism, TCP scaﬀolds were
implanted in the femur of rats and sacriﬁced after 1 day
and 8 weeks. After 8 weeks, new bone formation around
TCP scaﬀolds was visible by H&E staining (Figures 1(c)
and 1(d)). More in light with the early events taking place
during TCP/biomaterial, it was found that after 1 day
Table 1: The primer sequences used in RT-PCR.
Gene Organism Primer sequence
IL-10 Homo sapiens
Forward: 5′-GAGAAGCATGGCCCAGAAATC-3′
Reverse: 5′-GAGAAATCGATGACAGCGCC-3′
IL-1α Homo sapiens
Forward: 5′-CTCCAGCTGGAGGAAGTTAAC-3′
Reverse: 5′-CTGACTCAAAGCTGGTGGTG-3′
TNF-α Homo sapiens
Forward: 5′-CTGAACTTCGGGGTGATCGG-3′
Reverse: 5′-GGCTTGTCACTCGAATTTTGAGA-3′
IFN-γ Homo sapiens
Forward: 5′-GGCCATCAGCAACAACATAAGC-3′
Reverse: 5′-GGGTTGTTGACCTCAAACTTGG-3′
ARG1 Homo sapiens
Forward: 5′-GCCCTTTGCTGACATCCTA-3′
Reverse: 5′-CACCAGGCTGATTCTTCCGT-3′
CD206 Homo sapiens
Forward: 5′-GGGTTGCTATCACTCTCTATGC-3′
Reverse: 5′-TTTCTTGTCTGTTGCCGTAGTT-3′
RUNX2 Homo sapiens
Forward: 5′-CTGTGGCATGCACTTTGACC-3′
Reverse: 5′-GACCCTGACTTTTCGGGGAG-3′
OCN Homo sapiens
Forward: 5′-GCAAAGGTGCAGCCTTTGTG-3′
Reverse: 5′-GGCTCCCAGCCATTGATACAG-3′
ALP Homo sapiens
Forward: 5′-TCAGAAGCTAACACCAACG-3′
Reverse: 5′-TTGTACGTCTTGGAGAGGGC-3′
OSX Homo sapiens
Forward: 5′-CAACCTGCTAGAGATCTGAG-3′
Reverse: 5′-TGCAATAGGAGAGAGCGA-3′
GAPDH Homo sapiens
Forward: 5′-TCAGCAATGCCTCCTGCAC-3′
Reverse: 5′-TCTGGGTGGCAGTGATGGC-3′
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in vivo, macrophages gathered around the TCP particles
prior to bone regeneration (Figures 1(a), 1(b), 1(e), and 1(f)).
Experiments from our in vitro data further demonstrated
that TCP stimulates BMSC osteogenic diﬀerentiation. Firstly,
since TCP is mineralized and can be stained with alizarin red
(ARS), we utilized TCP extract for all the in vitro experi-
ments. As illustrated in Figures 1(b)–1(d), the extract of
TCP scaﬀolds signiﬁcantly upregulated osteogenic diﬀerenti-
ation markers when compared to the control group
(Figures 1(b)–1(d)). Furthermore, the impact of inﬂamma-
tion can be markedly seen through the positive role of anti-
inﬂammatory mediator IL-4, whereas a negative role was
observed in the proinﬂammatory mediators which included
LPS during osteoblast diﬀerentiation. Compared to the con-
trol group, stimulation of Thp1 with the supernatant of the
TCP extract induced signiﬁcantly better osteogenic diﬀer-
entiation (Figure 1). We therefore began to focus on the
role of macrophage induced via TCP during BMSC osteo-
genic diﬀerentiation to investigate a potential mechanism
for this action.
3.2. TCP Scaﬀolds Facilitate M2 Macrophage Polarization.
Previous studies have reported that TCP scaﬀolds can modify
the immune microenvironment towards one that favours
osteogenesis by switching themacrophage phenotype towards
an M2 polarization [23]. Therefore, we decided to evaluate
the anti-inﬂammatory ability of TCP through M1- (TNF-α,
IFN-γ) and M2- (CD206, ARG1) associated markers and
cytokines. Stimulation of Thp1 cells with TCP extract resulted
in a shift towards the M2 phenotype with higher expression
of M2 markers and lower expression of M1-associated cyto-
kines (Figure 2(a)). The PCR results (Figure 2(b)) demon-
strated that the most signiﬁcant change in inﬂammatory
gene expression occurred at 2 h, 4 h, and 24 h and therefore
conﬁrmed that changes occur rapidly when macrophages
are in contact with TCP.
3.3. The Inhibition of EZH1 Caused by TCP Facilitates M2
Macrophage Polarization. There have been a large volume
of published studies describing the role of methylase activity
during macrophage polarization [15–17]. EZH1, part of a
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Figure 1: Osteogenic eﬀect and gathering of macrophages at the healing defects ﬁlled with TCP. (a) (A–D) Representative sections of
hematoxylin-eosin staining. Macrophages are indicated by red arrows. (E) Representative sections of immunohistochemistry staining with
F4/80 antibody. Macrophages are indicated by red arrows. (F) Representative sections of immunohistochemistry staining with CD206
antibody. M2 macrophages are indicated by red arrows. (A,C) Scale bar = 50μm; (B, D, E, and F) scale bar = 20 μm. (b) Relative mRNA
expression of ALP, OCN, OSX, and Runx2 of HBMSC stimulated by control medium, supernatant of control Thp1, LPS, IL-4, and TCP
extract and supernatant of TCP-induced Thp1. (c) Alizarin red staining, ALP staining, and quantiﬁcation of HBMSC stimulated by control
medium, supernatant of control Thp1, LPS, IL-4, and TCP extract and supernatant of TCP-induced Thp1. (d) Quantiﬁcation of the areas
of alizarin red staining and ALP staining was measured by ImageJ software. ∗p < 0 05, ∗∗p < 0 01, ∗∗∗p < 0 001, and ∗∗∗∗p < 0 0001.
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noncanonical PRC2 complex, speciﬁcally catalyzes H3K27 to
prevent the derepression of PRC2 target genes. Further study
showed that stimulation with TCP extracts signiﬁcantly
inhibited the gene expression and protein production of
EZH1 when compared to the control group (Figures 3(a)
and 3(b)).
In order to conﬁrm the role of EZH1 during macrophage
polarization, we silenced EZH1 in Thp1 cells with siRNA
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Figure 2: TCP facilitates M2 macrophage polarization. (a) Relative mRNA expression of TNF-α, IFN-γ, CD206, and ARG1 of Thp1
stimulated by control medium, LPS, IL-4, and TCP extract. (b) Relative mRNA expression of TNF-α, IL-1α, CD206, and IL-10 of Thp1
stimulated by TCP extract at diﬀerent time points. ∗p < 0 05, ∗∗p < 0 01, ∗∗∗p < 0 001, and ∗∗∗∗p < 0 0001.
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Figure 3: Inhibition of EZH1 caused by TCP stimulation facilitates M2 macrophage polarization. (a) Relative mRNA expression of EZH1 of
Thp1 stimulated by TCP extract at diﬀerent time points. (b) Western blot of EZH1 expression of Thp1 stimulated by TCP extract at diﬀerent
time points. (c) Relative mRNA expression of EZH1 of Thp1 cells after EZH1 knockdown. (d) Western blot of EZH1 expression of Thp1 cells
after EZH1 knockdown. (e) Relative mRNA expression of TNF-α, IFN-γ, CD206, and ARG1 of Thp1 cells after EZH1 knockdown and
stimulation by TCP extract. ∗p < 0 05, ∗∗p < 0 01, ∗∗∗p < 0 001, and ∗∗∗∗p < 0 0001.
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(Figures 3(c) and 3(d)). By analysing gene expression of mac-
rophagepolarizationmarkers, itwas found that siEZH1signif-
icantly inhibited M2 macrophage polarization (Figure 3(e)).
3.4. The Inhibition of EZH1 Expression Is Associated with the
Inhibition of the NF-κB Pathway. Data from several studies
have also identiﬁed a role of the NF-κB pathway during mac-
rophage polarization [1]. In the process of M1 polarization,
the NF-κB pathway is activated, which activates the tran-
scription of M1-associated factors such as TNF-α and IFN-
γ. Since the stimulation of TCP aﬀects macrophages in less
than 1h, signiﬁcant inhibition of p-p65 (one of the markers
of NF-κB pathway activation) was found (Figure 4(a)). How-
ever, after the silencing of EZH1, there was no signiﬁcant dif-
ference between the siEZH1 group and the control group
(Figure 4(b)). We therefore hypothesized that the NF-κB
pathway may be responsible for the inhibition of EZH1.
In order to determine the role of the NF-κB pathway dur-
ing EZH1 inhibition, an inhibitor for the NF-κB pathway
(BMS-345541) was utilized. It was found that it signiﬁcantly
aﬀected the potency against IKK-1 and IKK-2 and subse-
quently inhibited the phosphorylation of p65. When treated
with BMS-345541, the expression of EZH1 was signiﬁcantly
downregulated (Figure 4(c)), and since the NF-κB pathway
was inhibited, M2 macrophage polarization was upregulated
(Figure 4(d)).
4. Discussion
The function of biological materials is associated with their
mechanical and physicochemical properties [24]; however,
their osteogenic eﬀect is mainly dependent on their histo-
compatibility once implanted into host tissues. When a bio-
material is implanted, the body’s immune system responds
quickly, causing a brief, acute inﬂammatory response that
leads to adaptive immunity [25]. The traditional view of the
body’s immune response is seen as a role of negative regula-
tion to tissue repair function of biomaterials [26]. Recently,
however, more studies have found the other sides of the
immune regulation to tissue repair.
Macrophages are a group of well-known antigen-
presenting cells. During tissue repair, they participate in
almost every biological process after biomaterial implanta-
tion including the initial immune process, angiogenesis, mes-
enchymal stem cell recruitment, and diﬀerentiation [27–29].
Many in vivo studies have now shown that M1 macrophages
dominate in the early process of tissue repair, while the M2
phenotypes are produced later during the process. Macro-
phages are however able to speciﬁcally polarize under various
stimuli to either M1 (proinﬂammatory) or M2 (anti-inﬂam-
matory) phenotypes [29].
When it comes to biomaterials as TCP, cells derived from
the monocyte/macrophage lineage is well known to be one of
the ﬁrst cell types contacting with biomaterials implanted [3].
As shown in Figure 1(b), here, they are able to speciﬁcally
polarize under various stimuli to either M1 or M2 pheno-
types or diﬀerentiate into osteoclasts or mutinucleated osteo-
clasts around TCP during TCP resorption [30]. There have
been various previous papers that characterized these osteo-
clasts as foreign body giant cells which are associated with
biomaterial rejection. Therefore, more recently, phenotypes
of these osteoclasts have been associated with tissue
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Figure 4: The inhibition of EZH1 expression is associated with the inhibition of the NF-κB pathway. (a) Western blot of the NF-κB signalling
pathway of Thp1 stimulated by TCP extract at diﬀerent time points. (b) Western blot of the NF-κB signalling pathway of Thp1 cells after
EZH1 knockdown and stimulation by TCP extract. (c) Relative mRNA expression of EZH1 of Thp1 cells after the inhibition of the NF-κB
pathway and stimulation by TCP extract. (d) Relative mRNA expression of TNF-α, IFN-γ, CD206, and ARG1 of Thp1 cells after the
inhibition of the NF-κB pathway and stimulation by TCP extract. ∗p < 0 05 and ∗∗p < 0 01.
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regeneration and wound healing by researches demonstrat-
ing that even mutinucleated osteoclasts may be characterized
as a tissue repair phenotype by demonstrating release of M2-
related cytokines and growth factors [31].
In the present study, a positive role of macrophages in
regulating bone repair was observed in response to TCP
both in vivo and in vitro. Our results showed that macro-
phages gathered around TCP particles early during the bone
repair. Once adhered, they express many surface molecules
and cytokines that inﬂuences the surrounding microenvi-
ronment. To better understand the inﬂuence of TCP on
macrophage polarization, we stimulated Thp1 cells with
extracts from TCP in vitro. The result demonstrated a
decreased expression of M1 marker genes (IFN-γ, TNF-α)
while an increased expression of M2 markers (TGF-beta,
VEGF) was observed.
Histone methylation plays a crucial role in macrophage
polarization [32], but the epigenetic mechanism in the pro-
cess mediated by TCP remains unclear. Previously, our
research group found that EZH1 could regulate NF-κB target
genes through a nonclassical complex that was associated
with SUZ12 and UTX. It was revealed that the polarization
process of macrophages was mainly activated by the corre-
sponding transcription factors through the NF-κB and
JAK-STAT pathways [1]. After activation, many transcrip-
tion factors bind to promoter regions of M1 marker genes
and begin their transcription [33]. In our study, we also
observed that NF-κB was repressed following stimulation
with TCP extracts.
Classic NF-κB consists of P50 and RelA (P65); the bind-
ing site of RelA 5′-AGAAATTCC-3′ was found in the pro-
moter region of EZH1 gene sequence, but to date, there is
no proof regarding the regulation of NF-κB to EZH1 [34].
Therefore, we blocked NF-κB with BMS-345541, an inhibitor
of the NF-κB pathway, and found that the expression of
EZH1 decreased signiﬁcantly with/without TCP stimulation.
EZH1 belongs to the polycomb family, which can compen-
sate the function of EZH1 in the PRC2 complex to catalyze
H3K27me3 through the SET domain, leading to gene tran-
scription inhibition. To investigate the role of EZH1 during
macrophage polarization, we silenced EZH1 with siRNA.
The expression of M1 markers including TNF-α and IFN-γ
was both signiﬁcantly decreased with or without TCP stimu-
lation, which implied a positive role for EZH1 during the pro-
cess of macrophages polarizing towards the M1 phenotype.
We assume that there may be two potential mechanisms
regarding the function of EZH1 as follows: (1) according to
our previous study, EZH1 may interact with NF-κB on the
promoter regions of NF-κB target genes, which is associated
with M1 macrophage polarization and (2) as a marker for
gene inhibition, EZH1 may target proximal sites on the pro-
moter region of Tollip, a transcription factor that suppresses
the NF-κB pathway [35], which results in an enhancement of
the NF-κB pathway.
5. Conclusions
In the present study, it was found that TCP suppressed the
activation of the NF-kappa B pathway and caused a decrease
in EZH1 expression. The reduction of EZH1 impacted the
downregulation of M1 marker genes, which resulted in a
lower expression of M1 cytokines. These lower proinﬂamma-
tory factors promoted a local microenvironment more
favourable for bone regeneration. EZH1 seems to play an
important role during the process of macrophage polariza-
tion and therefore might be an ideal target gene for future
therapies aimed at modifying macrophage polarization fol-
lowing biomaterial implantation into host tissues.
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